Getting identical performance from lab to commercial scale is tough, but DMC’s platform tech makes it happen with efficient development, scaling, and commercialization of biobased products. DMC’s Kenny Erdoes shared this illuminating slide guide at ABLC 2023 in Washington DC recently.
Use your ← → (arrow) keys to browse